Tonix Pharmaceuticals Presents Two Oral Presentations And One Poster Presentation Involving TNX-1500 At The American Transplant Congress 2024
TNX-1500 displays potential as a monotherapy or combination therapy to prevent rejection in organ transplantation in allograft and xenograft animal models Research Directed by Faculty of the Center for